Jeffrey Cherian, DO
Orthopaedic Surgery · Lancaster, PANPI 1003170820
Payments from drug & device makers
Across 53 payments — averaging $233.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$8K
- Zimmer Biomet$2K
- Johnson & Johnson$1K
- Encore Medical, LP$809
- Medical Device Business Services, Inc.$508
- Novus Surgical Consultants$411
- plus $550 from 5 others
What the payments were for
- Travel & lodging$1,59513%
- Food & beverage$2,00916%
- Education$8,78571%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 3 | $7,525 |
| Zimmer Biomet | 15 | $1,560 |
| Johnson & Johnson | 2 | $1,026 |
| Encore Medical, LP | 14 | $809 |
| Medical Device Business Services, Inc. | 8 | $508 |
| Novus Surgical Consultants | 4 | $411 |
| Stryker | 3 | $289 |
| Innovation Technologies Inc | 1 | $114 |
| Omnilife Science, Inc | 1 | $80 |
| Skeletal Dynamics Inc | 1 | $52 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ACTIS$1,026
- DJO SURGICAL$440
- ROSA$199
- MAKO$173
- DJO Surgical AltiVate Reverse$133
- DJO Surgical CLP Hip System$114
- DJO Surgical Cobalt HV Bone Cement$114
- DJO Surgical 3DKnee System$114
- Irrisept$114
- GAMMA$100
How this compares
$12,390 in reported general payments places this provider in the 70th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 69 | $842 |
| Methylprednisolone | 74 | $478 |
| Cefadroxil | 81 | $402 |
| Oxycodone Hcl | 103 | $326 |
| Tramadol Hcl | 129 | $244 |
| Gabapentin | 66 | $221 |
| Meloxicam | 69 | $98 |
| Mupirocin | 15 | $75 |
| Ondansetron OdtOndansetron | 28 | $71 |
| Amoxicillin | 23 | $58 |
| Ondansetron Hcl | 15 | $29 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Lancaster
- Michael BercikLancaster$214K
- William HozackBensalem$10.6M
- Jess LonnerBryn Mawr$8.1M
- Gerald WilliamsBryn Mawr$6.8M
- Mark LazarusBensalem$6.4M
- John FenlinPhiladelphia$5.9M
- Peter SharkeyKing Of Prussia$5.7M
- Selene ParekhBensalem$4.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$4.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.